The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis

Glenmark Pharmaceuticals List of Tables Table 1 List of secondary sources Table 2 List of abbreviations Table 3 Global GLP-1 receptor agonist market, by region, 2021-2033 (USD Million) Table 4 Global GLP-1 receptor agonist market, by product, 2021-2033 (USD Million) Table 5 Global GLP-1 receptor agonist market, by application, 2021-2033 (USD Million) Table 6 Global GLP-1 receptor agonist market, by route of administration, 2021-2033 (USD Million) Table 7 Global GLP-1 receptor agonist market, by distribution channel, 2021-2033 (USD Million) Table 8 North America GLP-1 receptor agonist market, by country, 2021-2033 (USD Million) Table 9 North America GLP-1 receptor agonist market, by product, 2021-2033 (USD Million) Table 10 North America GLP-1 receptor agonist market, by application, 2021-2033 (USD Million) Table 11 North America GLP-1 receptor agonist market, by route of administration, 2021-2033 (USD Million) Table 12 North America GLP-1 receptor agonist market, by distribution channel, 2021-2033 (USD Million) Table 13 U.S

Conclusion The GLP-1 RAs in people with obesity or type 2 diabetes are associated with a significant reduction in all-cause death, alongside an increased risk of pancreatic adverse eventsparticularly acute pancreatitismost pronounced during the first 6 months of treatment
Gliatto MF, Rai AK
Schmidt AC, Leroux JC Drug discovery today 2020